The role of complement in kidney disease
V Petr, JM Thurman - Nature Reviews Nephrology, 2023 - nature.com
The complement cascade comprises soluble and cell surface proteins and is an important
arm of the innate immune system. Once activated, the complement system rapidly generates …
arm of the innate immune system. Once activated, the complement system rapidly generates …
Complement in human disease: approved and up-and-coming therapeutics
EE West, T Woodruff, V Fremeaux-Bacchi, C Kemper - The Lancet, 2023 - thelancet.com
The complement system is recognised as a protector against blood-borne pathogens and a
controller of immune system and tissue homoeostasis. However, dysregulated complement …
controller of immune system and tissue homoeostasis. However, dysregulated complement …
Therapeutic targeting of the complement system in ocular disease
The complement system is involved in the pathogenesis of several ocular diseases,
providing a rationale for the investigation of complement-targeting therapeutics for these …
providing a rationale for the investigation of complement-targeting therapeutics for these …
Complement inhibitors for kidney disease
B Wooden, B Tarragon… - Nephrology Dialysis …, 2023 - academic.oup.com
ABSTRACT A refined understanding of the role of complement in the pathogenesis of
glomerular and other kidney diseases has, over the past two decades, been matched by the …
glomerular and other kidney diseases has, over the past two decades, been matched by the …
[HTML][HTML] Efficacy and safety of iptacopan in patients with C3 glomerulopathy
E Wong, C Nester, T Cavero, A Karras… - Kidney international …, 2023 - Elsevier
Introduction Complement 3 glomerulopathy (C3G) is a rare inflammatory kidney disease
mediated by dysregulation of the alternative complement pathway. No targeted therapy …
mediated by dysregulation of the alternative complement pathway. No targeted therapy …
Novel agents for treating IgA nephropathy
U Kunter, C Seikrit, J Floege - Current Opinion in Nephrology and …, 2023 - journals.lww.com
Novel agents for treating IgA nephropathy : Current Opinion in Nephrology and
Hypertension Novel agents for treating IgA nephropathy : Current Opinion in Nephrology …
Hypertension Novel agents for treating IgA nephropathy : Current Opinion in Nephrology …
Novel therapeutics and future directions for refractory immune thrombocytopenia
H Al‐Samkari, EJ Neufeld - British Journal of Haematology, 2023 - Wiley Online Library
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder affecting
approximately 1 in 20 000 people. While most patients with ITP are successfully managed …
approximately 1 in 20 000 people. While most patients with ITP are successfully managed …
[HTML][HTML] Challenges in IgA nephropathy management: an era of complement inhibition
IgA nephropathy (IgAN) is the most common glomerular disease worldwide, with an
estimated annual incidence of 25 per million adults. Despite optimized supportive care …
estimated annual incidence of 25 per million adults. Despite optimized supportive care …
IgA nephropathy: an overview of drug treatments in clinical trials
H Selvaskandan, G Gonzalez-Martin… - Expert Opinion on …, 2022 - Taylor & Francis
ABSTRACT Introduction IgA nephropathy (IgAN) is the commonest primary
glomerulonephritis worldwide and may progress to end-stage kidney disease (ESKD) within …
glomerulonephritis worldwide and may progress to end-stage kidney disease (ESKD) within …
Complement inhibitors in pediatric kidney diseases: new therapeutic opportunities
L Antonucci, JM Thurman, M Vivarelli - Pediatric Nephrology, 2024 - Springer
Historically, the complement system (classical, lectin, alternative, and terminal pathways) is
known to play a crucial role in the etiopathogenesis of many kidney diseases. Direct or …
known to play a crucial role in the etiopathogenesis of many kidney diseases. Direct or …